Patents
Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118)
01/2005
01/06/2005US20050004381 Therapy for headaches; analgesics; nausea; anxiolytic agents; anticonvulsants; central nervous system disorders
01/06/2005US20050004192 Inhibiting virus's own RNA-dependent RNA polymerase, NS5B
01/06/2005US20050004115 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
01/06/2005US20050004038 Therapy for drug resistant cancer, malaria,hematopoiesis
01/06/2005US20050002864 1,3-glyceride compound having two iodophenyl groups
01/05/2005EP1155138B1 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives
01/05/2005CN1560025A Synthesis process of theancine
01/04/2005US6838580 Opioid derivative
01/04/2005CA2109482C Process for producing alanylglutamine
12/2004
12/30/2004US20040267051 By reacting aldehydes or ketones with ammonia or primary/secondary amines in presence of hydrogen-donor and homogeneous transition metal/complex catalysts
12/30/2004US20040267025 Compounds for the treatment of metabolic disorders
12/30/2004US20040267012 5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
12/30/2004US20040266881 Acetamidobenzamide compounds for neurodegenerative disorders
12/30/2004US20040266873 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof
12/30/2004US20040266870 Inhibitors of the chemotactic activation induced by the fraction C5a of complement and from other chemotactic proteins (chemokines) that y activate a 7-transmembrane-domain receptor; psoriasis, rheumatoid arthritis, ulcerative colitis, acute respiratory distress syndrome, fibrosis; antiischemic agents
12/30/2004US20040266822 Secondary amines; tissue specificity; reduced side effects; cardiovascular diseases, diabetes, bronchial and urinary smooth muscle spasms, ischemia, anoxic nerve injury
12/30/2004US20040266718 Inhibition of specific histone deacetylase isoforms
12/29/2004WO2004113272A1 Process and intermediates for the preparation of 3-(amino)-3-cyclobutylmethyl-2-hydroxy-propionamide or salts thereof
12/29/2004WO2004002940A8 Inhibitors of hcv ns5b polymerase
12/29/2004EP1490337A2 Pro-dyes containing compositions for dyeing keratinous fibers
12/29/2004EP1490328A1 Compositions and methods for inhibition of phospholipase a2 mediated inflammation
12/29/2004EP1490054A2 Hemiasterlin derivatives and uses thereof in the treatment of cancer
12/29/2004EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004EP1073643B1 New heterocyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/29/2004CN1558905A Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
12/29/2004CN1557841A Process for synthetic extraction of polysaccharides, tea-polyphenol, theanine, caffeine from tea
12/29/2004CN1182107C Hydroxamic acid derivative as inhibitor of formation of soluble human CD23
12/28/2004US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004US6835712 Compounds
12/28/2004CA2143805C Process for the preparation and purification of iodinated contrast agents
12/23/2004WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004CA2526387A1 Benzamide derivative or salt thereof
12/22/2004EP1489068A1 Multidentate ligand, multi-nucleus metal complex, metal complex chain, metal complex integrated structure, and preparation method thereof
12/22/2004EP1487788A1 Diaminoacid-aminoacid-polyamine based gemini surfactant compounds
12/22/2004EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/22/2004EP0927030B1 Use of aryl n-substituted carboxamides to kill tumors
12/22/2004CN1556095A Tetracycline derivatives
12/22/2004CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/21/2004US6833365 Such as 5-propionyl-6-cyclopentylsulfanylmethyl doxycycline; for treating diarrhea in immunodeficient individuals
12/21/2004CA2317604C Matrix metalloprotease inhibitors
12/16/2004WO2004052939A3 Ligands for metals and improved metal-catalyzed processes based thereon
12/16/2004US20040254344 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
12/16/2004US20040254225 Modulation of opioid receptor by binding
12/15/2004EP1485346A1 Novel positively charged lipids and liposomes comprising the positively charged lipids
12/15/2004EP1485107A1 Phospholipids as caspase inhibitor prodrugs
12/15/2004EP1485079A2 Small molecule entry inhibitors
12/15/2004EP1034783B1 Amide derivatives for the treatment of retinal neurodegenerative disorders
12/15/2004CN1555364A Insecticidal diamides
12/15/2004CN1554642A Process for preparing theanine
12/15/2004CN1179944C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
12/14/2004CA2195841C Process and intermediates for (s)-.alpha.-amino-1-carboxycyclopentaneacetic acid
12/14/2004CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/09/2004WO2004106283A1 Amino alcohol derivative, medicinal composition containing the same, and uses of these
12/09/2004WO2004105740A1 Polyhydroxy phenols and their use in bindng p-selectin
12/09/2004US20040248947 N-(3- and 4-substituted phenyl)-2-(arylamino)-benzamides; aralkylation of the 2-primary amine with a benzaldehyde or a pyrid-4-yl carbaldehyde; anticarcinogenic, antitumor agents; enzyme inhibitors of vascular endothelial growth factors
12/09/2004US20040248815 Substituted amino acids as erythropoietin mimetics
12/09/2004US20040248811 increased oral bioavailability and reduced dosage and regime; epilepsy; pain syndrome therapy
12/08/2004EP1483578A2 Artificial receptors, building blocks, and methods
12/08/2004EP1483242A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
12/08/2004EP1483228A1 Nk1 antagonists
12/08/2004EP1482926A2 Amino-methyl substituted tetracycline compounds
12/08/2004EP1224164B1 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23
12/08/2004EP1127052B1 Substituted 2-phenylbenzimidazoles, the production thereof and their use
12/08/2004CN1178905C Novel peptide derivative
12/08/2004CN1178901C New-cyclic alpha-amino-gamma hydroxy amide compound and its preparing method and medicinal composition containing said compound
12/08/2004CN1178899C Preparation of iodixanol
12/07/2004US6828458 Topical antiandrogen for hair loss and other hyperandrogenic conditions
12/07/2004US6828335 Oxazole or thiazole-ethyl-oxy-indane acetic acid derivatives; useful for the treatment of diseases such as diabetes, obesity, hyperlipidemia and atherosclerosis
12/02/2004WO2004103954A1 Amide derivative
12/02/2004US20040242868 Controlling cytokines; antiinflammatory agents; rheumatic disoreders; skin disorders; respiratory system disorders; Alzheimer's disease; Parkinson's disease; Huntington"s disease ; amyotrophic lateral sclerosis
12/02/2004US20040242692 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis
12/02/2004US20040242652 Beta benzyloxyaspartate derivatives with amino group on benzene ring
12/01/2004EP1480999A2 (substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
12/01/2004CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004CN1177810C A process for the preparation of S-N,N'-bis [2-hydroxy-1-(hydroxymethyl)ethyl]-5-[(2-hydroxyl-1-oxopropyl)amino]- 2,4,6-triio do-1,3-benzenedicarboxamide
11/2004
11/30/2004US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/25/2004WO2004100950A1 ‘(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/25/2004WO2004084842A3 Inhibitors of cathepsin s
11/25/2004WO2003101945A8 Ligands that are inhibitors of the rar receptors
11/25/2004US20040236150 Process for the preparation of iopamidol
11/25/2004US20040236107 Intermediate compounds for the preparation of mirtazapine and the production methods thereof
11/25/2004US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004US20040235959 Insecticidal diamides
11/25/2004US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004US20040235835 For prophylaxis of of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis
11/25/2004US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004CA2525006A1 `(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)-propyl!phenyl derivatives as beta2 agonists
11/24/2004EP1479666A1 Ester compound and medicinal use thereof
11/24/2004EP1183231B1 Cytofectin dimers and methods of use thereof
11/24/2004CN1176941C Caspase inhibitors and the use thereof
11/24/2004CN1176918C Intermediate of alpha-substituted benzene acetic acid derivate with farm pesticide activity
11/23/2004US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004CA2201845C Reactive amine catalysts and their use in polyurethane polymers
11/18/2004WO2004098512A2 Malonamides and malonamide derivatives as modulators of chemokine receptor activity
11/18/2004WO2004071434A3 MONO, DI & TRI CYCLIC COMPOUNDS USEFUL FOR LOWERING IgE CONCENTRATIONS
11/18/2004WO2004024755A3 Sarcolysyl derivatives and method for the production thereof
11/18/2004US20040229984 Gelling agent for oil
11/18/2004US20040229904 Compounds useful for the treatment of diseases
1 ... 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 ... 162